Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 14742320)

Published in Carcinogenesis on January 23, 2004

Authors

Gary G Schwartz1, Dawn Eads, Anuradha Rao, Scott D Cramer, Mark C Willingham, Tai C Chen, Daniel P Jamieson, Lilin Wang, Kerry L Burnstein, Michael F Holick, Constantinos Koumenis

Author Affiliations

1: Department of Cancer Biology, Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

Articles citing this

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51

Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J (2004) 1.94

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res (2009) 1.67

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.37

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J (2010) 1.32

Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer (2010) 1.19

Vitamin D and cancer. Front Endocrinol (Lausanne) (2012) 1.15

DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther (2010) 1.02

Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol (2013) 0.97

Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem. Int J Environ Res Public Health (2009) 0.95

Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada. PLoS One (2013) 0.95

Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol (2009) 0.92

Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem (2013) 0.90

Vitamin D and pancreatic cancer. Ann Epidemiol (2008) 0.90

Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. J Steroid Biochem Mol Biol (2007) 0.88

Role of vitamin d in the prevention of pancreatic cancer. J Nutr Metab (2011) 0.88

Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med (2011) 0.87

1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D--mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells. Eur J Nutr (2005) 0.86

Is dietary fat, vitamin D, or folate associated with pancreatic cancer? Mol Carcinog (2012) 0.86

Nutrigenomics, vitamin D and cancer prevention. J Nutrigenet Nutrigenomics (2011) 0.86

25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst (2014) 0.81

Vitamins in Pancreatic Cancer: A Review of Underlying Mechanisms and Future Applications. Adv Nutr (2015) 0.80

Resveratrol stimulates cortisol biosynthesis by activating SIRT-dependent deacetylation of P450scc. Endocrinology (2012) 0.80

Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo. Oncotarget (2016) 0.79

Vitamin D and GI cancers: shedding some light on dark diseases. Ann Transl Med (2014) 0.78

Vitamin d and pancreatic cancer-an update. Cancers (Basel) (2011) 0.78

Upregulation of 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase by butyrate in Caco-2 cells. World J Gastroenterol (2005) 0.78

Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer. Nutr J (2016) 0.77

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. J Clin Oncol (2016) 0.77

PLGA nanoparticles as a platform for vitamin D-based cancer therapy. Beilstein J Nanotechnol (2015) 0.77

Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Am J Clin Nutr (2015) 0.76

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃. Int J Mol Sci (2016) 0.75

Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells. Int J Mol Sci (2017) 0.75

Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation. Front Oncol (2017) 0.75

Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget (2017) 0.75

Insulin resistance in vitamin D-deficient mice is alleviated by n-acetylcysteine. Oncotarget (2017) 0.75

Vitamin D deficiency causes insulin resistance by provoking oxidative stress in hepatocytes. Oncotarget (2017) 0.75

Articles by these authors

Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr (2008) 7.61

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr (2003) 6.50

The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99

Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol (2008) 4.72

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16

ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J (2005) 3.79

The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J (2010) 3.76

Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab (2007) 3.36

Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers. Clin Cancer Res (2007) 3.30

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nat Med (2008) 3.08

Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest (2007) 3.01

Vitamin D deficiency: what a pain it is. Mayo Clin Proc (2003) 2.90

Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev (2013) 2.87

Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem (2008) 2.87

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med (2007) 2.83

Vitamin D insufficiency among free-living healthy young adults. Am J Med (2002) 2.80

Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila) (2007) 2.43

Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J (2006) 2.41

Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41

Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys (2007) 2.39

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37

Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer. Clin Cancer Res (2009) 2.35

Bile acid transporters. J Lipid Res (2009) 2.31

Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity (2008) 2.26

Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Natl Cancer Inst (2003) 2.26

Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol (2007) 2.20

Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid (2002) 2.18

Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res (2007) 2.15

Plasma 25-hydroxyvitamin D levels in young children undergoing placement of tympanostomy tubes. Ann Otol Rhinol Laryngol (2008) 2.13

A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc (2007) 2.12

Mesothelin expression in human lung cancer. Clin Cancer Res (2007) 2.10

Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol (2005) 2.01

Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res (2011) 2.00

A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology (2004) 1.99

Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr (2010) 1.97

Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96

The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther (2006) 1.94

Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med (2010) 1.94

Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem (2002) 1.92

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet (2009) 1.90

Vitamin D intakes by children and adults in the United States differ among ethnic groups. J Nutr (2005) 1.88

The epidemic status and genetic diversity of 14 highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) isolates from China in 2009. Vet Microbiol (2011) 1.88

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer (2010) 1.87

ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest (2012) 1.85

Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol (2005) 1.84

Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One (2010) 1.83

Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest (2014) 1.81

Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients (2013) 1.81

Control of the hypoxic response through regulation of mRNA translation. Semin Cell Dev Biol (2005) 1.81

Too little vitamin D in premenopausal women: why should we care? Am J Clin Nutr (2002) 1.79

Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr (2004) 1.79

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A (2006) 1.77

Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitness. Pediatrics (2010) 1.76

ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation (2004) 1.76

Synthesis of vitamin D in skin after burns. Lancet (2004) 1.75

Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem (2005) 1.75

Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc (2005) 1.74

A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res (2011) 1.74

Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med (2009) 1.73

19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo. Cancer Biol Ther (2007) 1.73

A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab (2010) 1.69

Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children. Obesity (Silver Spring) (2008) 1.69

Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells. Mol Cancer Ther (2004) 1.68

Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab (2004) 1.67

An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol (2005) 1.67

Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66

Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples. Clin Chem (2006) 1.66

Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Res (2007) 1.64

Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab (2008) 1.61

International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev (2006) 1.60

Vitamin D intake in the United States. J Am Diet Assoc (2004) 1.58

Adsorption of hydroxyl- and amino-substituted aromatics to carbon nanotubes. Environ Sci Technol (2008) 1.56

20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am J Physiol Cell Physiol (2010) 1.54

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology (2004) 1.53

Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism. J Hepatol (2012) 1.51

Deficiency of sunlight and vitamin D. BMJ (2008) 1.49

Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol (2011) 1.49

Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab (2011) 1.49

Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids. Am J Physiol Gastrointest Liver Physiol (2005) 1.45

Correlating pre-operative vitamin d status with post-thyroidectomy hypocalcemia. Endocr Pract (2014) 1.45

The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev (2012) 1.44

Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant (2006) 1.44